8VWE image
Deposition Date 2024-02-01
Release Date 2025-07-02
Last Version Date 2025-07-02
Entry Detail
PDB ID:
8VWE
Title:
HIV-1 neutralizing antibody D5_AR bound to HIV-1 gp41 coiled-coil pocket IQN17
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
HIV-1 M:B_HXB2R (Taxon ID: 11706)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
H 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transmembrane protein gp41 IQN17 peptide
Chain IDs:B (auth: C)
Chain Length:45
Number of Molecules:1
Biological Source:HIV-1 M:B_HXB2R
Polymer Type:polypeptide(L)
Molecule:Neutralizing antibody D5_AR Heavy Chain
Chain IDs:A (auth: H)
Chain Length:222
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Neutralizing antibody D5_AR Light Chain
Chain IDs:C (auth: L)
Chain Length:214
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Utilizing Machine Learning to Improve Neutralization Potency of an HIV-1 Antibody Targeting the gp41 N-Heptad Repeat.
Acs Chem.Biol. ? ? ? (2025)
PMID: 40540236 DOI: 10.1021/acschembio.5c00035

Abstact

The N-heptad repeat (NHR) of the HIV-1 gp41 prehairpin intermediate (PHI) is an attractive potential vaccine target with high sequence conservation across diverse strains. However, despite the potency of NHR-targeting peptides and clinical efficacy of the NHR-targeting entry inhibitor enfuvirtide, no potently neutralizing NHR-directed monoclonal antibodies (mAbs) nor antisera have been identified or elicited to date. The lack of potent NHR-binding mAbs both dampens enthusiasm for vaccine development efforts at this target and presents a barrier to performing passive immunization experiments with NHR-targeting antibodies. To address this challenge, we previously developed an improved variant of the NHR-directed mAb D5, called D5_AR, which is capable of neutralizing diverse tier-2 viruses. Building on that work, here we present the 2.7Å-crystal structure of D5_AR bound to NHR mimetic peptide IQN17. We then utilize protein language models and supervised machine learning to generate small (n < 100) libraries of D5_AR variants that are subsequently screened for improved neutralization potency. We identify a variant with 5-fold improved neutralization potency, D5_FI, which is the most potent NHR-directed monoclonal antibody characterized to date and exhibits broad neutralization of tier-2 and -3 pseudoviruses as well as replicating R5 and X4 challenge strains. Additionally, our work highlights the ability of protein language models to efficiently identify improved mAb variants from relatively small libraries.

Legend

Protein

Chemical

Disease

Primary Citation of related structures